Konstantin Leskov

6PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Deep learningInnate immunityEpigenetics (incl. genome methylation and epigenomics)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Michael L Freeman, Brian M Clagett, Konstantin Leskov

|Sep 27, 2025
HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency.

Leah M Plasek Hegde, Lalith S Gunawardane, Farshad Niazi

|Apr 26, 2024
Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation.

Fredrick Kizito, Kien Nguyen, Uri Mbonye

|Sep 05, 2023
Single cell multiomic analysis reveals diabetes-associated β-cell heterogeneity driven by HNF1A.

Chen Weng, Anniya Gu, Shanshan Zhang

|Jul 21, 2021
Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.

Iart Luca Shytaj, Francesco Andrea Procopio, Mohammad Tarek

Pageof 1